Long term disease modification using immunostimulatory oligonucleotides

Details for Australian Patent Application No. 2007333368 (hide)

Owner Dynavax Technologies Corporation

Inventors Hessel, Edith; Coffman, Robert L.

Agent Davies Collison Cave

Pub. Number AU-A-2007333368

PCT Pub. Number WO2008/073661

Priority 60/865,089 09.11.06 US

Filing date 9 November 2007

Wipo publication date 19 June 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/073661 Priority application(s): WO2008/073661

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333369-Electrospinning process

2007333355-Microemulsion dosage forms of valsartan and methods of making the same